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Objective. Resorbable collagen membranes (RCMs) are commonly used by oral surgeons, periodontists, and endodontists for
multiple purposes. We report 6 cases of RCMs that did not resorb as expected and describe the histopathologic features.
Study Design. Cases of an unusual fibrillar foreign material were noted in biopsy specimens curetted from bone.
Hematoxylin-eosin and Masson trichrome stains were performed. Clinicians were contacted for detailed clinical information.
Results. There were 3 men and 3 women. RCMs presented as hyalinized, paucicellular, delicate eosinophilic fibrils or a
meshwork without a foreign body reaction. They were refractile and stained for Masson trichrome as expected. These RCMs
persisted longer than expected (2-6 weeks) in 3 cases and may have retarded healing in 5 cases.
Conclusions. AlthoughRCM is supposed to be fairly rapidly resorbable, thismaterial sometimes persistswithinwound siteswithout
any obvious foreign body reaction and may retard healing. (Oral Surg Oral Med Oral Pathol Oral Radiol 2014;118:236-240)Resorbable collagen membranes (RCMs) are manu-
factured from allogeneic or xenogeneic sources to
manage oral wounds such as extraction sockets, for
sinus-lift procedures and repairs, and for periodontal or
endodontic surgeries.1-4 They act as scaffolds for bone
deposition in guided bone regeneration (GBR), promote
platelet aggregation, stabilize clots, and attract ﬁbro-
blasts, facilitating wound healing.5-7 They are designed
to resorb within 2 to 32 weeks and are biocompatible,
easy to manipulate, and only weakly immunogenic.7-9
They are available as membranes, plugs, or pads for
ease of use.
The objective of this report is to describe 6 cases of
retained resorbable collagen membranes noted in oral
curettage specimens and to describe the histopathology
of this exogenous material.
MATERIALS AND METHODS
Cases of an unusual ﬁbrillar foreign material were noted
in biopsy specimens accessioned from StrataDx Inc,
Lexington, MA, USA, from January 2013 to December
2013. Patient history and clinical and radiographic
features were obtained by contacting the clinicians by
telephone. Hematoxylin-eosin and Masson trichrome
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Six cases were identiﬁed. The demographic data, history,
and clinical information are presented in Table I. The
biopsy specimens were from 3 men and 3 women. Five
cases were curettage specimens from the bone and were
biopsied because of a persistent radiolucency or delayed
healing (Figure 1), and the sixth case represented acci-
dental contamination of a biopsy specimen during an
apicoectomy when the membrane was placed for he-
mostasis (see Table I). In 5 cases, resorbable collagen
was used for ridge augmentation, for GBR, to control
bleeding in an extraction socket, to ﬁll a defect after
removal of a recurrent keratocystic odontogenic tumor
(KCOT), and for hemostasis after an apicoectomy.Histopathologic findings
All cases (except case 6, which represented contami-
nation) showed granulation and ﬁbrous tissue with a
variable lymphoplasmacytic inﬁltrate consistent with a
healing wound. In all cases, there were hyalinized
eosinophilic strands of ﬁbrillar material resembling
collagen (Figures 2 and 3). Some of the eosinophilic
strands were present in a meshwork, or as thinner, more
delicate ﬁbrils appearing to be in the process of disin-
tegration (Figure 4, A, B); these ﬁbrils were separated
by ﬁbrous connective tissue containing ﬁbroblasts with
scattered lymphocytes. A foreign body giant cellStatement of Clinical Relevance
Resorbable collagen membranes are commonly used
by oral surgeons, periodontists, and endodontists for
multiple purposes. They generally resorb fairly
rapidly but sometimes may persist within wound
sites without any obvious foreign body reaction and
may retard healing.
Table I. Summary of cases, demographic data, and clinical features
Case No.
Age/
gender History/collagen product use Reason for surgery
Time since collagen
product use
Case 1
eSlide: VM00235
and VM00234
58/F Ridge augmentation using RCM6 Biopsy of right maxillary vestibule for
recurrent infection after ridge
augmentation
12 weeks
Case 2
eSlide: VM00233
84/M Extraction of right mandibular ﬁrst and second
molar; OsseoGuard placed for GBR
Persistent granulation tissue within socket
6 weeks after extraction
6 weeks
Case 3
eSlide: VM00232
71/M Extraction of right mandibular third molar;
CollaTape placed
Persistent radiolucency of socket for 2
months
8 weeks
Case 4
eSlide: VM00231
47/F Curettage of area between the right
mandibular ﬁrst and second premolars
(history of KCOT there); CollaTape placed
Persistent radiolucency 4 weeks
Case 5
eSlide: VM00230
75/M Sinus tract, apicoectomy; CollaTape placed Persistent sinus tract 4 weeks
Case 6
eSlide: VM00236
68/F Apicoectomy of left maxillary second molar;
CollaPlug placed
Persistent periapical radiolucency 0*
GBR, guided bone regeneration; KCOT, keratocystic odontogenic tumor.
*CollaPlug was placed at the same time as apicoectomy specimen was submitted. Accidental contamination occurred.
Fig. 1. Case 2. Persistent ulcerated granulation tissueelike
mass extruding from extraction sockets of teeth 30 and 31
(right mandibular ﬁrst and second molars).
Fig. 2. Case 1. Hyalinized, acellular eosinophilic strands of
ﬁbrillar material resembling collagen with ﬁbrosis and mild
chronic inﬂammation (hematoxylin-eosin, original magniﬁ-
cation  100). A high-resolution version of this slide is
available as eSlide VM00235.
Fig. 3. Case 5. Hyalinized, acellular eosinophilic strands of
collagen, partially degraded with ﬁbrosis and chronic inﬂamma-
tion (hematoxylin-eosin, original magniﬁcation  100). A high-
resolution version of this slide is available as eSlide VM00230.
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from the surrounding collagen because of its lack of
cellularity (Figure 5). However, it was refractile in a
fashion similar to collagen (Figure 6). It also stained
positively with the Masson trichrome stain (Figure 7).
There was no evidence of osteoid or woven bone for-
mation in any of the cases.
Fig. 4. A, Case 3. Collagen membrane in process of degradation with a mesh-like appearance (top) or as delicate, short ﬁbrils
(bottom) (hematoxylin-eosin, original magniﬁcation 200). A high-resolution version of this slide is available as eSlide VM00232.
B, Case 2. Collagen membrane in process of degradation with both thicker, intact bands (top) and more delicate, thin ﬁbrils (center)
(hematoxylin-eosin, original magniﬁcation 400). A high-resolution version of this slide is available as eSlide VM00233.
Fig. 5. Case 1. Collagen membrane showing lack of cellu-
larity, insinuated by ﬁbrous tissue, in the process of degra-
dation (hematoxylin-eosin, original magniﬁcation 400). A
high-resolution version of this slide is available as eSlide
VM00235.
Fig. 6. Case 1. Collagen membrane strands are refractile in
polarized light, similar to normal collagen (hematoxylin-
eosin, original magniﬁcation 200).
Fig. 7. Case 1. Collagen membrane stains in a manner similar
to, but more intense than, that of normal collagen (Masson
trichrome, original magniﬁcation 100). A high-resolution
version of this slide is available as eSlide VM00234.
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Collagen is an insoluble ﬁbrous protein that is an
essential component of the connective tissue stroma.
There are at least 16 types of collagen found in inter-
stitial tissues, matrix of bone, cartilage, epithelial and
blood vessel basement membrane, and the vitreous of
the eye, among others.10 Type I, II, and III collagen
constitute 80% to 90% of the body’s collagen;
commercially available collagen products are composed
mainly of type 1 collagen.9 Many of the most
commonly used collagen membranes are derived from
bovine tendon11,12 (Table II). Cross-linkage between
collagen molecules (such as with formaldehyde or
glutaraldehyde)11-13 during the manufacturing process
strengthens the collagen ﬁbrils, increases their stability,
prolongs resorption time, and increases biocompati-
bility. Resorption of collagen membranes occurs
through biodegradation by inﬂammatory cells.14 In
Table II. The most commonly used commercially available resorbable collagen membranes
Commercial name (manufacturer) Collagen type Collagen source Resorption rate
CollaTape/CollaPlug/CollaCote (Integra LifeSciences Corp, Plainsboro, NJ, USA) Type I Bovine tendon 10-14 days
Periogen (Collagen Corporation, Palo Alto, CA, USA) Type I and III Bovine dermis 4-8 weeks
BioMend (Collagen Matrix Inc, Franklin Lakes, NJ, USA) Type I Bovine tendon 6-8 weeks
BioMend extend (Collagen Matrix Inc) Type I Bovine tendon 18 weeks
Ossix (Datum Dental Ltd, Lod, Israel) Type I Porcine tendon 4-6 months
Bio-Gide (Geistlich, Wolhusen, Switzerland) Type I and III Porcine skin 24 weeks
OsseoGuard (Collagen Matrix Inc) Type I Bovine tendon 6-9 months
OsseoGuard Flex (Collagen Matrix Inc) Type I and III Bovine dermis 6-9 months
RCM6 (ACE Surgical Supply Co Inc, Brockton, MA, USA) Type I Bovine tendon 26-38 weeks
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CollaCote (Integra LifeSciences Corp, Plainsboro, NJ,
USA), a rapidly resorbable collagen membrane derived
from bovine tendon; subsequently, many of the other
commercially available membranes were approved in
1990.15 Resorbable collagen membranes are commer-
cially available as membranes alone (see Table II) or
impregnated with other materials such as bone
morphogenic protein (Infuse; Medtronic Inc, Minne-
apolis, MN, USA).7,16
Resorbable collagen membranes are frequently used
as wound dressings because they act as a scaffold, pro-
mote platelet aggregation, stabilize clots, and attract ﬁ-
broblasts, facilitating wound healing; they are therefore
often used for GBR.7,9,17,18 Other applications for these
collagen products include ridge augmentation and
grafting of extraction sockets, as well as for sinus lift
procedures, the repair of sinus membrane tears, soft tis-
sue recontouring, and GBR during apicoectomy.7,9,19,20
Historically, collagen membranes exhibit variable
resorption times ranging from 4 to 32 weeks, and the
choice of material depends on the intended use.8,9 If the
intended use is GBR, a more durable collagen mem-
brane with longer resorption time such as OsseoGuard
(Collagen Matrix Inc, Franklin Lakes, NJ, USA) may
be used because of its reported 6- to 9-month resorption
period.8 However, if the intended use is simply to
control bleeding, products with the shortest reported
resorption time of 10 to 14 days, such as CollaTape,
CollaPlug, and CollaCote (Integra LifeSciences Corp),
may be preferable.7
In this report, we describe the clinical and histo-
pathologic ﬁndings of resorbable collagen membrane in
6 patients. The membrane material resembled collagen
both in its refractile properties under polarized light and
in the characteristic staining with Masson trichrome
stain. However, the morphology of this material was
different from that of native collagen in that the
resorbable collagen exhibited acellular strands of hya-
linized material often noted to be in the process of
disintegration into short and narrow ﬁbrils, or a mesh-
work, with associated ﬁbrosis and chronic inﬂammation.In 3 cases, the resorbable collagen was used to ﬁll
bone defects or control bleeding, and in 2 cases, it was
placed for GBR and ridge augmentation (see Table I).
In case 1, an infection occurred 3 months after ridge
augmentation. Remnants of RCM6 collagen membrane
(ACE Surgical Supply Co Inc, Brockton, MA, USA)
were seen in the biopsy specimen, an expected obser-
vation given that the reported resorption time is 6
months or more.
In case 2, the clinical wound did not heal for 6 weeks
after tooth extractions (see Figure 1), leading the
clinician to perform a biopsy. Remnants of OsseoGuard
membrane (Collagen Matrix Inc) were seen, as ex-
pected given that the reported resorption time is 6
months; but there was no evidence of new bone for-
mation 6 weeks after the procedure. In general, reepi-
thelialization occurs within 4 weeks, osteoid starts to ﬁll
the extraction socket by 2 to 4 weeks, woven bone by 8
weeks, and lamellar bone by 12 weeks.21-24 Similarly,
in cases 3, 4, and 5 there was persistence of CollaTape
(Integra LifeSciences Corp) 8 weeks after extraction, 4
weeks after curettage of a KCOT, and 4 weeks after
apicoectomy, respectively, although this membrane is
reported to typically undergo resorption within 2
weeks. The biopsies did not show signiﬁcant new bone
formation, and this is particularly striking in case 3,
which was evaluated 8 weeks after extraction.
Although reossiﬁcation appeared to be delayed in
some cases, it is unclear if the collagen membrane
contributed to this. What is clear is that in 3 of 5 cases
in which the time of insertion was known, the mem-
brane did not resorb in the timeframe expected. Despite
this, the material appeared to be inert and did not elicit a
foreign body reaction.
CONCLUSION
In this report, we describe the histopathologic appear-
ance of resorbable collagen membranes. The majority
of cases were from curettage specimens of persistent
radiolucencies within bone. This material differs from
endogenous collagen in its organization and
morphology but is identical in its refractility and
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Although resorbable collagen membrane is supposed to
be fairly rapidly resorbable, this material sometimes
persists within wound sites without any obvious foreign
body reaction.
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